SG
BSX icon

StoneX Group’s Boston Scientific BSX Stock Holding History

StoneX Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$441K Buy
7,030
+2,135
+44% +$171K 0.02% 458
2025
Q4 		$467K Sell
4,895
-337
-6% -$33K 0.02% 554
2025
Q3 		$511K Sell
5,232
-680
-12% -$70.4K 0.02% 524
2025
Q2 		$635K Buy
5,912
+322
+6% +$32.6K 0.03% 438
2025
Q1 		$564K Sell
5,590
-252
-4% -$25.4K 0.03% 442
2024
Q4 		$522K Buy
+5,842
New +$514K 0.03% 458

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

StoneX Group's BSX Position: Q1 2026 in Review

StoneX Group increased its Boston Scientific (BSX) stake by 44% in Q1 2026, buying an estimated $171K and bringing the position to 7,030 shares worth $441K. The position accounts for 0.02% of the portfolio, ranked #458.

StoneX Group first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $635K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • StoneX Group held 7,030 shares of Boston Scientific worth $441K as of Q1 2026.
  • StoneX Group bought 2,135 Boston Scientific shares in Q1 2026, an estimated $171K.
  • Boston Scientific made up 0.02% of StoneX Group's portfolio in Q1 2026, its #458 holding.
  • StoneX Group first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • StoneX Group's Boston Scientific position peaked at $635K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.